|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Induced Nuclear Accumulation
1 Program in Membrane Biology, Massachusetts General Hospital, Charlestown, MA, USA; Renal Unit, Massachusetts General Hospital, Charlestown, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA
2 Program in Membrane Biology, Massachusetts General Hospital, Charlestown, MA, USA; Renal Unit, Massachusetts General Hospital, Charlestown, MA, USA
3 Renal Unit, Massachusetts General Hospital, Charlestown, MA, USA
4 Molecular Cardiology Research Institute, New England Medical Center, Boston, MA, USA
* To whom correspondence should be addressed. E-mail: b.roelen{at}nki.nl.
Smad4, the common Smad, is central for TGF-
superfamily ligand signaling. Smad4 has been shown to be constitutively phosphorylated, but the site(s) of phosphorylation, the kinase(s) that performs this phosphorylation, and the significance of the phosphorylation of Smad4 are currently unknown. This report describes the identification of a consensus Erk phosphorylation site in the linker region of Smad4 at Thr 276. Our data show that Erk can phosphorylate Smad4 in vitro, but not Smad4 with mutated Thr276. Flag-tagged Smad4-T276A mutant protein accumulates less efficiently in the nucleus after stimulation by TGF-
, and is less efficient in generating a transcriptional response than Smad4-wildtype protein. Tryptic phosphopeptide mapping identified a phosphopeptide in Smad4-wild type protein that was absent in phosphorylated Smad4-T276A mutant protein. Our results suggest that MAP kinase can phosphorylate Thr276 of Smad4, and that phosphorylation can lead to enhanced TGF-
-induced nuclear accumulation, and as a consequence enhanced transcriptional activity of Smad4.
This article has been cited by other articles:
![]() |
G. Ramey, J.-C. Deschemin, and S. Vaulont Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes Haematologica, June 1, 2009; 94(6): 765 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki, M. C. Wilkes, N. Garamszegi, M. Edens, and E. B. Leof Transforming Growth Factor {beta} Signaling via Ras in Mesenchymal Cells Requires p21-Activated Kinase 2 for Extracellular Signal-Regulated Kinase-Dependent Transcriptional Responses Cancer Res., April 15, 2007; 67(8): 3673 - 3682. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Buck, M. Buchholz, M. Wagner, G. Adler, T. Gress, and V. Ellenrieder The Tumor Suppressor KLF11 Mediates a Novel Mechanism in Transforming Growth Factor {beta}-Induced Growth Inhibition That Is Inactivated in Pancreatic Cancer Mol. Cancer Res., November 1, 2006; 4(11): 861 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liang, Y.-Y. Liang, K. Wrighton, D. Ungermannova, X.-P. Wang, F. C. Brunicardi, X. Liu, X.-H. Feng, and X. Lin Ubiquitination and Proteolysis of Cancer-Derived Smad4 Mutants by SCFSkp2 Mol. Cell. Biol., September 1, 2004; 24(17): 7524 - 7537. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |